Literature DB >> 23884401

Use the duodenum, it’s right there: a retrospective cohort study comparing biliary reconstruction using either the jejunum or the duodenum.

J Bart Rose, Phillip Bilderback, Tal Raphaeli, William Traverso, Scott Helton, John A Ryan, Thomas Biehl.   

Abstract

IMPORTANCE: This is the largest series to date comparing end-to-side biliary reconstruction for all indications performed using either the duodenum or jejunum and with at least 2-year follow-up.
OBJECTIVE: To demonstrate that duodenal anastomoses for biliary reconstruction are at least as safe and effective as Roux-en-Y jejunal anastomoses, with the benefits of operative simplicity and ease of postoperative endoscopic evaluation. DESIGN, SETTING, AND PARTICIPANTS: Retrospective record review with telephone survey of patients undergoing nonpalliative biliary reconstruction in the hepatopancreatobiliary surgery division of a high-volume tertiary care facility.
INTERVENTIONS: Biliary reconstruction via either end-to-side Roux-en-Y jejunal anastomosis or direct duodenal anastomosis. MAIN OUTCOMES AND MEASURES: The primary end points were anastomosis-related complications (leak, cholangitis, bile gastritis, or stricture), and the secondary end points were overall complications, endoscopic or radiologic interventions, readmissions, and death.
RESULTS: Ninety-six nonpalliative biliary reconstructions were performed between February 1, 2000, and November 23, 2011 for bile duct injury, cholangiocarcinoma, choledochal cysts, or benign strictures; the procedures included 59 duodenal reconstructions and 37 Roux-en-Y jejunal reconstructions. The groups were similar with regard to demographics, operative indications, postoperative length of stay, and mortality rates. However, anastomosis-related complications (leaks, cholangitis, or strictures) were fewer in the duodenal than the jejunal cohort (7 patients [12%] vs 13 [35%]; P = .009). Of patients with stricture, 5 of 9 in the jejunal cohort required percutaneous transhepatic access for management compared with only 1 of 2 in the duodenal cohort. CONCLUSIONS AND RELEVANCE: Duodenal anastomosis is a safe, simple, and often preferable method for biliary reconstruction. This anastomosis can successfully be performed to all levels of the biliary tree with low rates of leak, stricture, cholangitis, and bile gastritis. When anastomotic complications do occur, there is less need for transhepatic intervention because of easier endoscopic access.

Entities:  

Mesh:

Year:  2013        PMID: 23884401     DOI: 10.1001/jamasurg.2013.2701

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


  5 in total

1.  Biliary Bypass with Laparoscopic Choledochoduodenostomy.

Authors:  Joshua K Kays; Leonidas G Koniaris; Daniel P Milgrom; Attila Nakeeb
Journal:  J Gastrointest Surg       Date:  2018-01-16       Impact factor: 3.452

2.  A nationwide assessment of outcomes after bile duct reconstruction.

Authors:  Mariam F Eskander; Lindsay A Bliss; Osman K Yousafzai; Susanna W L de Geus; Sing Chau Ng; Mark P Callery; Tara S Kent; A James Moser; Khalid Khwaja; Jennifer F Tseng
Journal:  HPB (Oxford)       Date:  2015-06-20       Impact factor: 3.647

Review 3.  Hybrid laparoscopic-robotic management of type IVa choledochal cyst in the setting of prior Roux-en-Y gastric bypass: video case report and review of the literature.

Authors:  Julietta Chang; R Matthew Walsh; Kevin El-Hayek
Journal:  Surg Endosc       Date:  2014-12-10       Impact factor: 4.584

Review 4.  Roux-en-Y hepaticojejunostomy or hepaticoduodenostomy for biliary reconstruction after resection of congenital biliary dilatation: a systematic review and meta-analysis.

Authors:  Chengbo Ai; Yang Wu; Xiaolong Xie; Qi Wang; Bo Xiang
Journal:  Surg Today       Date:  2022-01-21       Impact factor: 2.549

5.  Management of Injury to the Common Bile Duct in a Patient with Roux-en-Y Gastric Bypass.

Authors:  Sheraz Yaqub; Tom Mala; Oystein Mathisen; Bjørn Edwin; Bjarte Fosby; Dag Tallak Kjærsdalen Berntzen; Andreas Abildgaard; Knut Jørgen Labori
Journal:  Case Rep Surg       Date:  2014-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.